Emami Ltd is primarily active in the healthcare and wellness, personal care, and beauty industries.

The main competitors of Emami Ltd in the market include companies such as Hindustan Unilever Limited, Marico Limited, and Dabur India Limited.

Emami Ltd is an Indian multinational company that was founded in 1974 by Mr. R.S. Agarwal and Mr. R.S. Goenka. It started as a small Ayurvedic medical clinic in Kolkata and gradually expanded its product portfolio to include personal care, healthcare, and beauty products. Emami Ltd is known for its popular brands like Navratna Oil, Boroplus, Fair and Handsome, and Kesh King. Over the years, the company has grown exponentially and gained a strong foothold in the Indian market. Emami Ltd continues to innovate and provide quality products, catering to the diverse needs of its customers, making it a trusted name in the industry.

Emami Ltd has achieved several significant milestones in its business journey. Over the years, the company has successfully expanded its product portfolio, diversified its operations, and gained a strong market presence. Emami Ltd has witnessed remarkable growth, becoming one of the leading players in the FMCG industry. The company has launched numerous innovative and quality products in various segments, including personal care, healthcare, and beauty. Emami Ltd has also received prestigious awards and recognition for its excellence and contributions to the industry. With continuous advancements and strategic partnerships, Emami Ltd continues to thrive and make a lasting impact in the market.

Emami Ltd is primarily present in India, with its headquarters in Kolkata. As a leading Indian conglomerate, Emami Ltd operates across various sectors including healthcare, personal care, and beauty products. With a significant presence in India, Emami Ltd has a widespread distribution network, reaching out to consumers across the country. It has also expanded its reach to several international markets, including countries in the Middle East, Africa, and the United States. As a globally recognized company, Emami Ltd continues to expand its footprint and reach new markets to cater to the diverse needs of its customers.

Emami Ltd represents values such as innovation, excellence, and integrity in its corporate philosophy. The company is committed to delivering high-quality products and services to enhance the lives of its customers. Emami Ltd focuses on continuous improvement and growth, incorporating sustainability and social responsibility into its operations. As a leading player in the personal care and healthcare sectors, Emami Ltd strives for customer satisfaction and aims to create long-term value for its stakeholders. Emami Ltd's dedication to research and development, coupled with its customer-centric approach, sets it apart as a trusted and respected brand in the market.

Analysts currently set an average price target of 671,28 INR for the Emami stock (median: 663,00 INR), implying +64,1 % versus the latest price. The consensus is based on 31 analyst ratings.

Emami Elemzői célárfolyamok 2026

31 analysts currently rate the Emami stock: 26 recommend buying, 5 holding and 0 selling. For 2026, analysts expect Emami to generate revenue of 38,88 Md INR and earnings per share of 19,66 INR.

Emami Elemzői célárfolyamok 2026

Converted at the current exchange rate, the Emami share trades at 3,66 EUR (402,35 INR).

Emami Ltd is an Indian company that was founded in 1974 and is headquartered in Kolkata. The company operates in various sectors such as personal care, cosmetics, healthcare, and food. The personal care division is one of the key business areas for Emami Ltd. The company offers a wide range of products including oils, creams, lotions, shampoos, conditioners, and more that are needed for personal care. These products are sold under brands like Navratna, Boroplus, Fair and Handsome, Zandu Balm, etc. The cosmetics division includes products like lipsticks, nail polishes, kajal, face powders, eyeshadows, and more. These products are sold under brands like Elle 18, Lacto Calamine, and Kesh King. Emami Ltd is also involved in the production of ayurvedic cosmetic products, which are sold under the brand Fair and Handsome. Emami Ltd is also active in the healthcare sector and manufactures ayurvedic products that are sold under the brand Zandu. The product range of this business area includes health and wellness products such as Chyawanprash, medicinal oils, joint & muscle care, women's care, and more. In addition to these business areas, Emami Ltd is also engaged in food production. The company has a joint venture with the British company Bunge Limited, which focuses on the production of soybean oil, margarine, and mayonnaise. The company is also involved in the production of spice blends, such as the famous Zandu Pancharista blend. Emami Ltd's business model is based on offering high-quality products at competitive prices. The company has a clear strategy to achieve continuous growth and customer satisfaction through innovation and targeted investments in research and development. Emami Ltd also conducts aggressive advertising campaigns to increase the company's image and brand awareness. Emami Ltd sells its products through a network of retail and distribution outlets as well as through online platforms. The company operates several retail chains in India under different brands. Emami Ltd also pursues an omnichannel strategy to provide customers with even better service and stronger customer proximity. In summary, Emami Ltd is a company that operates in various sectors and offers a wide range of products and services. The company has a clear strategy to achieve continuous growth and ensure customer satisfaction. Emami Ltd's business model is based on innovation, quality, and competitiveness, and the company's aggressive advertising campaign helps to increase the company's image and brand awareness.

A várható bevétele Emami 38,88 Md INR. Ez az érték az aktuális pénzügyi adatokon alapul, és a vállalat üzleti teljesítményét tükrözi.

A várható nyeresége Emami 8,58 Md INR. A nettó nyereség a vállalat nyereségességét tükrözi az összes költség levonása után.

A Emami ár/nyereség mutatója (P/E) jelenleg 20,47. A P/E mutató az aktuális részvényárat az egy részvényre jutó nyereséggel hasonlítja össze, és segít a befektetőknek a Emami részvény értékelésének megértésében.

A Emami ár/értékesítés mutatója (P/S) jelenleg 4,52. A P/S mutató a piaci kapitalizációt az éves bevételhez hasonlítja, és a Emami részvény értékelési mérőszámaként szolgál.

Az Eulerpool minőségi pontszáma a Emami számára 7/10.

A Emami ISIN-je INE548C01032. Az ISIN (International Securities Identification Number) a nemzetközi securities azonosító.

A Emami ticker-e EMAMILTD.NS. A ticker szimbólum a Emami részvény tőzsdei kereskedésénél használatos.

Az elmúlt 12 hónapban a(z) Emami osztalékot fizetett 10,00 INR összegben. Ez körülbelül 2,49 % osztalékhozamnak felel meg. A következő 12 hóban a(z) Emami várhatóan 14,40 INR összegű osztalékot fog fizetni.

A Emami jelenlegi osztalékrendítménye 2,49 %.

Emami osztalékot fizet, amelyet a(z) , , , hónapokban osztanak ki.

A Emami az elmúlt 19 évben minden évben fizetett osztalékot.

A következő 12 hónapban 14,40 INR összegű osztalékra számítanak. Ez 3,58 % osztalékhozamnak felel meg.

A(z) Emami a(z) 'Nem ciklikus fogyasztási cikkek' szektorhoz van besorolva.

Az utolsó, Emami által -án/én fizetett 6 INR összegű osztalék megszerzéséhez a részvénynek az ex-nap előtti -nál kellett lennie a portfóliódban.

Az utolsó osztalék kifizetése időpontban történt.

2025 évben a Emami 8 INR összegű osztalékot fizetett ki.

Az Emami osztalékait INR fizeti ki.